Outcome after re-irradiation of head and neck cancer patients

Strahlentherapie und Onkologie

Volumn 187, Issue 1, 2011, Pages 23-31

  Platteaux, Nele ^a   Dirix, Piet ^a   Vanstraelen, Bianca ^a   Nuyts, Sandra ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Head and neck cancer; Re irradiation; Survival; Toxicity

Indexed keywords

CARBOPLATIN; CETUXIMAB; CISPLATIN; DOCETAXEL; FLUOROURACIL;

ACUTE TOXICITY; ARTICLE; BONE NECROSIS; BRAIN NECROSIS; CANCER CONTROL; CANCER PATIENT; CANCER SURVIVAL; CONTROLLED STUDY; DYSPHAGIA; FISTULA; HEAD AND NECK CANCER; HUMAN; INTENSITY MODULATED RADIATION THERAPY; IRRADIATION; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; METASTASIS; MUCOSA INFLAMMATION; OPTIC NERVE DISEASE; OVERALL SURVIVAL; RADIATION DOSE; RECURRENT CANCER; RETROSPECTIVE STUDY; SKIN TOXICITY; TOXICITY; TREATMENT OUTCOME; UNIVARIATE ANALYSIS;

ADULT; AGED; BRACHYTHERAPY; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOPLASMS, SECOND PRIMARY; OTORHINOLARYNGOLOGIC NEOPLASMS; RADIATION INJURIES; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, CONFORMAL; RETREATMENT; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED; TUMOR BURDEN;

EID: 79951681987     PISSN: 01797158     EISSN: 1439099X     Source Type: Journal    
DOI: 10.1007/s00066-010-2139-9     Document Type: Article

References (56)

1. Berger B, Belka C, Weinmann, et al. Reirradiation with a alternating docetaxel-based chemotherapy for recurrent head and neck squamous cell carcinoma. Update of a single-center prospective phase II protocol. Strahlenther Onkol 2010;186: 255-61.
2. Biagioli MC, Harvey M, Roman E, et al. Intensity-modulated radiotherapy with concurrent chemotherapy for previously irradiated, recurrent head and neck cancer. Int J Radiat Oncol Biol Phys 2007;69:1067-73. (Pubitemid 47625850)
3. Bourhis J, Overgaard J, Audry H, et al. Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis. Lancet 2006;368:843-54. (Pubitemid 44292807)
4. Bussels B, Maes A, Hermans R, et al. Recurrences after conformal parotid- sparing radiotherapy for head and neck cancer. Radiother Oncol 2004;72:119-27. (Pubitemid 39024587)
5. Chua DT, Sham JS, Leung LH, et al. Re-irradiation of nasopharyngeal carcinoma with intensity-modulated radiotherapy. Radiother Oncol 2005;77:290-4. (Pubitemid 41785339)
6. Dawson LA, Anzai Y, Marsh L, et al. Patterns of local-regional recurrence following parotid-sparing conformal and segmental intensity-modulated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys 2000;46:1117-26. (Pubitemid 30139420)
7. Dawson LA, Myers LL, Bradford CR, Che et al. Conformal re-irradiation of recurrent and new primary head-and-neck cancer. Int J Radiat Oncol Biol Phys 2001;50:377-85. (Pubitemid 32472266)
8. De Crevoisier R, Bourhis J, Domenge C, et al. Full-dose reirradiation for unresectable head and neck carcinoma: experience at the Gustave-Roussy Institute in a series of 169 patients. J Clin Oncol 1998;16:3556-62. (Pubitemid 28506768)
9. De Crevoisier R, Domenge C, et al. Full dose reirradiation combined with chemotherapy after salvage surgery in head and neck carcinoma. Curr Opin Oncol 2001;91:2071-6. (Pubitemid 32476371)
10. Emami B, Bignardi M, Spector GJ, et al. Reirradiation of recurrent head and neck cancers. Laryngoscope 1987;97:85-8. (Pubitemid 17226024)
11. Forastiere AA, Metch B, Schuller DE, et al. Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: a Southwest Oncology Group study. J Clin Oncol 1992;10:1245-51.
12. Forastiere AA, Shank D, Neuberg D, et al. Final report of a phase II evaluation of paclitaxel in patients with advanced squamous cell carcinoma of the head and neck: an Eastern Cooperative Oncology Group trial (PA390). Cancer 1998;82:2270-4. (Pubitemid 28240836)
13. Gandia D, Wibault P, Guillot T, et al. Simultaneous chemoradiotherapy as salvage treatment in locoregional recurrences of squamous head and neck cancer. Head Neck 1993;15:8-15. (Pubitemid 23003466)
14. Garofalo MC, Haraf DJ. Reirradiation: a potentially curative approach to locally or regionally recurrent head and neck cancer. Curr Opin Oncol 2002;14:330-3. (Pubitemid 34492867)
15. Goldstein DP, Karnell LH, Yao M, et al. Outcomes following reirradiation of patients with head and neck cancer. Head Neck 2008;30:765-70. (Pubitemid 351913853)
16. Haraf DJ, Weichselbaum RR, Vokes EE. Re-irradiation with concomitant chemotherapy of unresectable recurrent head and neck cancer: a potentially curable disease. Ann Oncol 1996;7:913-8. (Pubitemid 26426265)
17. Hehr T, Classen J, Belka C, et al. Reirradiation alternating with docetaxel and cisplatin in inoperable recurrence of head-and-neck cancer: a prospective phase I/II trial. Int J Radiat Oncol Biol Phys 2005;61:1423-31. (Pubitemid 40470424)
18. Janot F, De Raucourt D, Benhamou E, et al. Randomized trial of postoperative reirradiation combined with chemotherapy after salvage surgery compared with salvage surgery alone in head and neck carcinoma. J Clin Oncol 2008;26:5518-23.
19. Jereczek-Fossa BA, Kowalczyk A, Donofrio A, et al. Three-dimensional conformal or stereotactic reirradiation of recurrent, metastatic or new primary tumors. Analysis of 108 patients. Strahlenther Onkol 2008;184:36-40.
20. Kao J, Garofalo MC, Milano MT, et al. Reirradiation of recurrent and second primary head and neck malignancies: a comprehensive review. Cancer Treat Rev 2003;29:21-30. (Pubitemid 36395520)
21. Kasperts N, Slotman BJ, Leemans CR, de Bree R, Doornaert P, Langendijk JA. Results of postoperative reirradiation for recurrent or second primary head and neck carcinoma. Cancer 2006;106(7):1536-47.
22. Langendijk JA, Bourhis J. Reirradiation in squamous cell head and neck cancer: recent developments and future directions. Curr Opin Oncol 2007;19:202-9. (Pubitemid 46597478)
23. Langendijk JA, Kasperts N, Leemans CR, et al. A phase II study of primary reirradiation in squamous cell carcinoma of head and neck. Radiother Oncol 2006;78:306-12.
24. Langer CJ, Harris J, Horwitz EM, et al. Phase II study of low-dose paclitaxel and cisplatin in combination with split-course concomitant twice-daily reirradiation in recurrent squamous cell carcinoma of the head and neck: results of Radiation Therapy Oncology Group Protocol 9911. J Clin Oncol 2007;25:4800-5. (Pubitemid 350086484)
25. Langlois D, Eschwege F, Kramar A, et al. Reirradiation of head and neck cancers. Presentation of 35 cases treated at the Gustave Roussy Institute. Radiother Oncol 1985;3:27-33. (Pubitemid 15160316)
26. Lee N, Chan K, Bekelman JE, et al. Salvage re-irradiation for recurrent head and neck cancer. Int J Radiat Oncol Biol Phys 2007;68:731-40. (Pubitemid 46818729)
27. Lee AW, Foo W, Law SC, et al. Reirradiation for recurrent nasopharyngeal carcinoma: factors affecting the therapeutic ratio and ways for improvement. Int J Radiat Oncol Biol Phys 1997;38:43-52. (Pubitemid 27270941)
28. Machtay M, Rosenthal DI, Chalian AA, et al. Pilot study of postoperative reirradiation, chemotherapy, and amifostine after surgical salvage for recurrent head-and-neck cancer. Int J Radiat Oncol Biol Phys 2004;59:72-7. (Pubitemid 38501509)
29. Nagar YS, Singh S, Datta NR. Chemo-reirradiation in persistent/recurrent head and neck cancers. Jpn J Clin Oncol 2004;34:61-8. (Pubitemid 43115320)
30. Nieder C, Milas L, Ang KK. Tissue tolerance to reirradiation. Semin Radiat Oncol 2000;10:200-9. (Pubitemid 30452636)
31. Nuyts S, Dirix P, Clement PM, et al. Impact of adding concomitant chemotherapy to hyperfractionated accelerated radiotherapy for advanced head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys 2009;73:1088-95.
32. Nuyts S, Dirix P, Hermans R, et al. Early experience with a hybrid accelerated radiotherapy schedule for locally advanced head and neck cancer. Head Neck 2007;29:720-30. (Pubitemid 47265527)
33. Munker R, Reitmeier M, Hartenstein R. Radiochemotherapy in head and neck neoplasms. Strahlenther Onkol 2000;176: 537-8.
34. Parsons JT, Mendenhall WM, Stringer SP, et al. Salvage surgery following radiation failure in squamous cell carcinoma of the supraglottic larynx. Int J Radiat Oncol Biol Phys 1995;32:605-9.
35. Pignon JP, Bourhis J, Domenge C, et al. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer. Lancet 2000;355:949-55. (Pubitemid 30148259)
36. Pignon JP, Le Maitre A, Bourhis J. Meta-Analyses of Chemotherapy in Head and Neck Cancer (MACH-NC): an update. Int J Radiat Oncol Biol Phys 2007;69(2 Suppl):S112-4. (Pubitemid 47369400)
37. Pomp J, Levendag PC, van Putten WL. Reirradiation of recurrent tumors in the head and neck. Am J Clin Oncol 1988;11:543-9.
38. Popovtzer A, Gluck I, Chepeha DB, et al. The pattern of failure after reirradiation of recurrent squamous cell head and neck cancer: implications for defining the targets. Int J Radiat Oncol Biol Phys 2009;1342-7.
39. Rades D, Stoehr M, Meyners T, et al. Evalaution of prognostic factors and two radiation techniques in patients treated with surgery followed by radio(chemo)therapy or definitive radio(chemo)therapy for locally advanced head-and-neck cancer. Strahlenther Onkol 2008;184:198-205. (Pubitemid 351508132)
40. Ridge JA. Squamous cancer of the head and neck: surgical treatment of local and regional recurrence. Semin Oncol 1993;20:419-29. (Pubitemid 23321468)
41. Salama JK, Vokes EE, Chmura SJ, et al. Long-term outcome of concurrent chemotherapy and reirradiation for recurrent and second primary head-andneck squamous cell carcinoma. Int J Radiat Oncol Biol Phys 2006;64:382-91. (Pubitemid 43083422)
42. Schaefer U, Micke O, Schueller P, et al. Recurrent head and neck cancer: retreatment of previously irradiated areas with combined chemotherapy and radiation therapy-results of a prospective study. Radiology 2000;216:371-6. (Pubitemid 30599851)
43. Schwartz LH, Ozsahin M, Zhang GN, et al. Synchronous and metachronous head and neck carcinomas. Cancer 1994;74:1933-8. (Pubitemid 24301857)
44. Spencer SA, Harris J, Wheeler RH, et al. RTOG 96-10: reirradiation with concurrent hydroxyurea and 5-fluorouracil in patients with squamous cell cancer of the head and neck. Int J Radiat Oncol Biol Phys 2001;51:1299-304. (Pubitemid 33116324)
45. Spencer SA, Wheeler RH, Peters GE, et al. Concomitant chemotherapy and reirradiation as management for recurrent cancer of the head and neck. Am J Clin Oncol 1999;22:1-5. (Pubitemid 30261579)
46. Stevens KR Jr., Britsch A, Moss WT. High-dose reirradiation of head and neck cancer with curative intent. Int J Radiat Oncol Biol Phys 1994;29:687-98. (Pubitemid 24241307)
47. Stupp R, Vokes EE. Advances in the treatment of head and neck tumors. Radiochemotherapy. Strahlenther Onkol 1995;171:140-8.
48. Sulman EP, Schwartz DL, Le TT, et al. IMRT reirradiation of head and neck cancer-disease control and morbidity outcomes. Int J Radiat Oncol Biol Phys 2009;73:399-409.
49. Temam S, Pape E, Janot F, et al. Salvage surgery after failure of very accelerated radiotherapy in advanced head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys 2005;62:1078-83. (Pubitemid 40884420)
50. Vokes EE, Weichselbaum RR, Lippman SM, et al. Head and neck cancer. N Eng J Med 1993;328:184-94.
51. Wang CC, McIntyre J. Re-irradiation of laryngeal carcinoma-techniques and results. Int J Radiat Oncol Biol Phys 1993;26:783-5.
52. Wang CC. Re-irradiation of recurrent nasopharyngeal carcinoma-treatment techniques and results. Int J Radiat Oncol Biol Phys 1987;13:953-6. (Pubitemid 17106921)
53. Weppelmann B, Wheeler RH, Peters GE, et al. Treatment of recurrent head and neck cancer with 5-fluorouracil, hydroxyurea, and reirradiation. Int J Radiat Oncol Biol Phys 1992;22:1051-6.
54. Wong SJ, Machtay M, Li Y. Locally recurrent, previously irradiated head and neck cancer: concurrent re-irradiation and chemotherapy, or chemotherapy alone? J Clin Oncol 2006;24:2653-8. (Pubitemid 46622086)
55. https://webapps.ctep.nci.nih.gov/ctcv3
56. http://www.rtog.org/members/toxicity/late.html